Cargando…

Role of microRNAs in type 2 diseases and allergen-specific immunotherapy

MicroRNAs (miRs) have gained scientific attention due to their importance in the pathophysiology of allergic diseases as well as their potential as biomarkers in allergen-specific treatment options. Their function as post-transcriptional regulators, controlling various cellular processes, is of high...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakwerth, Constanze A., Kitzberger, Hannah, Pogorelov, Dimitrii, Müller, Annika, Blank, Simon, Schmidt-Weber, Carsten B., Zissler, Ulrich M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512106/
https://www.ncbi.nlm.nih.gov/pubmed/36172292
http://dx.doi.org/10.3389/falgy.2022.993937
_version_ 1784797783015817216
author Jakwerth, Constanze A.
Kitzberger, Hannah
Pogorelov, Dimitrii
Müller, Annika
Blank, Simon
Schmidt-Weber, Carsten B.
Zissler, Ulrich M.
author_facet Jakwerth, Constanze A.
Kitzberger, Hannah
Pogorelov, Dimitrii
Müller, Annika
Blank, Simon
Schmidt-Weber, Carsten B.
Zissler, Ulrich M.
author_sort Jakwerth, Constanze A.
collection PubMed
description MicroRNAs (miRs) have gained scientific attention due to their importance in the pathophysiology of allergic diseases as well as their potential as biomarkers in allergen-specific treatment options. Their function as post-transcriptional regulators, controlling various cellular processes, is of high importance since any single miR can target multiple mRNAs, often within the same signalling pathway. MiRs can alter dysregulated expression of certain cellular responses and contribute to or cause, but in some cases prevent or repress, the development of various diseases. In this review article, we describe current research on the role of specific miRs in regulating immune responses in epithelial cells and specialized immune cells in response to various stimuli, in allergic diseases, and regulation in the therapeutic approach of allergen-specific immunotherapy (AIT). Despite the fact that AIT has been used successfully as a causative treatment option since more than a century, very little is known about the mechanisms of regulation and its connections with microRNAs. In order to fill this gap, this review aims to provide an overview of the current knowledge.
format Online
Article
Text
id pubmed-9512106
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95121062022-09-27 Role of microRNAs in type 2 diseases and allergen-specific immunotherapy Jakwerth, Constanze A. Kitzberger, Hannah Pogorelov, Dimitrii Müller, Annika Blank, Simon Schmidt-Weber, Carsten B. Zissler, Ulrich M. Front Allergy Allergy MicroRNAs (miRs) have gained scientific attention due to their importance in the pathophysiology of allergic diseases as well as their potential as biomarkers in allergen-specific treatment options. Their function as post-transcriptional regulators, controlling various cellular processes, is of high importance since any single miR can target multiple mRNAs, often within the same signalling pathway. MiRs can alter dysregulated expression of certain cellular responses and contribute to or cause, but in some cases prevent or repress, the development of various diseases. In this review article, we describe current research on the role of specific miRs in regulating immune responses in epithelial cells and specialized immune cells in response to various stimuli, in allergic diseases, and regulation in the therapeutic approach of allergen-specific immunotherapy (AIT). Despite the fact that AIT has been used successfully as a causative treatment option since more than a century, very little is known about the mechanisms of regulation and its connections with microRNAs. In order to fill this gap, this review aims to provide an overview of the current knowledge. Frontiers Media S.A. 2022-09-12 /pmc/articles/PMC9512106/ /pubmed/36172292 http://dx.doi.org/10.3389/falgy.2022.993937 Text en © 2022 Jakwerth, Kitzberger, Pogorelov, Müller, Blank, Schmidt-Weber and Zissler. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Allergy
Jakwerth, Constanze A.
Kitzberger, Hannah
Pogorelov, Dimitrii
Müller, Annika
Blank, Simon
Schmidt-Weber, Carsten B.
Zissler, Ulrich M.
Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
title Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
title_full Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
title_fullStr Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
title_full_unstemmed Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
title_short Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
title_sort role of micrornas in type 2 diseases and allergen-specific immunotherapy
topic Allergy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512106/
https://www.ncbi.nlm.nih.gov/pubmed/36172292
http://dx.doi.org/10.3389/falgy.2022.993937
work_keys_str_mv AT jakwerthconstanzea roleofmicrornasintype2diseasesandallergenspecificimmunotherapy
AT kitzbergerhannah roleofmicrornasintype2diseasesandallergenspecificimmunotherapy
AT pogorelovdimitrii roleofmicrornasintype2diseasesandallergenspecificimmunotherapy
AT mullerannika roleofmicrornasintype2diseasesandallergenspecificimmunotherapy
AT blanksimon roleofmicrornasintype2diseasesandallergenspecificimmunotherapy
AT schmidtwebercarstenb roleofmicrornasintype2diseasesandallergenspecificimmunotherapy
AT zisslerulrichm roleofmicrornasintype2diseasesandallergenspecificimmunotherapy